WellPoint Inc. (WLP) reported its first-quarter
income from continuing operations of $891.0 million or $2.35 per
share, surpassing the Zacks Consensus Estimate of $1.87. This also
compares favorably with the income of $871.9 million or earnings of
$1.95 in the year-ago quarter.
The improved showing was attributable to higher operating cash
flows and the implementation of organizational changes in health care.
Besides, the jump in medical enrollment also contributed to the
increase.
WellPoint’s
income from continuing operations excludes net investment gains of
$35.6 million after-tax, or 9 cents per share in the first quarter
of 2011; while net operating income in the first quarter of 2010
excludes net investment gains of $18.6 million after-tax or 4 cents
per share, which was partially offset by an intangible asset
impairment charge of $13.7 million after-tax, or 3 cents per
share.
Including
these one-time items, WellPoint reported a net income of $926.6
million or $2.44 per share in the first quarter of 2011 as opposed
to $876.8 million or $1.96 per share in the prior-year
quarter.
Behind the
Headlines
Total
operating revenues for the quarter came in at approximately $14.7
billion, lagging $14.8 billion by 1.3% from the year-ago quarter.
However, it was marginally ahead of the Zacks Consensus Estimate of
$14.6 billion.
The decline
in revenues reflected lower Commercial operating revenue resulting
primarily from the conversion of two large groups to self-funding
arrangements during 2010, partially offset by revenue growth driven
by increases in Senior, Federal Employee Program (“FEP”) and State
Sponsored membership.
However, it
was pleasing to see a significant jump in medical enrollment during
the reported quarter, with enrollment of 34.2 million members as on
March 31, 2011, an increase of 1.1% from 33.8 million as on March
31, 2010.
Growth of
members in the National business as well as growth in WellPoint's
Senior, State Sponsored and FEP businesses contributed in the
increase of medical enrollment. However, it was offset by
membership declines in the Individual and Local Group
businesses.
WellPoint posted a benefit expense ratio (benefit expenses as a
percentage of premium revenue) of 82.1% in the reported quarter as
against 81.8% in the first quarter of 2010, driven by higher
medical costs and membership growth in the Senior and State
Sponsored businesses.
Likewise, for Individual business, the benefit expense ratio
increased as WellPoint complied with minimum medical loss ratio
requirements in 2011. However, the Commercial segment faced a
decline in
benefit expense ratio, reflecting the conversion of two
large groups to self-funding arrangements during 2010 and lower
than anticipated medical costs in the first quarter of 2011.
On the other hand, the selling, general, and administrative
(SG&A) expense ratio (SG&A expenses as a percentage of
premiums, administrative services fees and other revenue) plummeted
to 14.2% in the first quarter of 2011 from 14.6% in the year-ago
quarter.
This represents a year-over-year increase of 40 basis points,
reflecting a 4.5% reduction in SG&A expense resulting from
lower personnel costs and the ongoing efficiency initiatives taken
up by WellPoint, which were partially offset by a decline in
operating revenue.
Segment Results
Commercial Business: Operating gains in the
segment increased 15.0% year over year to $1.13 billion in the
first quarter of 2011, owing to lower than anticipated medical
costs in the Local Group business and a reduction in SG&A
expense in the current year quarter.
Consumer Business: Operating gains in the
segment plummeted 36.9% year over year to $205.8 million in the
reported quarter, due to lower operating gains in the Senior
and State Sponsored businesses owing to higher medical costs.
Other: Operating gains in this segment
experienced an operating gain of $19.4 million in the first quarter
of 2011, compared with an operating loss of $17.7 million in the
first quarter of 2010. This was primarily driven by improved
results in the National Government Services business of WellPoint
and lower administrative expenses in the first quarter of 2011.
Evaluation of Capital Structure
WellPoint generated operating cash flow of $1.1 billion in the
first quarter of 2011, while the company generated a net cash
outflow from operations of $322.9 million in the first quarter of
2010 that included $1.2 billion of tax payments related to the sale
of the NextRx pharmacy benefit management subsidiaries to
Express Scripts (ESRX) in the fourth quarter of
2009.
At the end of March 31, 2011, cash and investments at the parent
company totaled approximately $2.4 billion.
During the reported quarter, WellPoint repurchased approximately
11.4 million shares for $741.6 million. As of March 31, 2011,
WellPoint’s board has $882.0 million remaining in its share
repurchase authorization.
WellPoint also paid a quarterly cash dividend of 25 cents per
share in the quarter, representing a distribution of cash totaling
$92.8 million.
During the first quarter of 2011, WellPoint witnessed net
investment gains of $54.7 million pre-tax, consisting of net
realized gains from the sale of securities totaling $57.1 million,
partially offset by other-than-temporary impairments totaling $2.4
million pre-tax.
In the prior year quarter, WellPoint experienced net investment
gains of $28.7 million pre-tax, consisting of net realized gains
from the sale of securities totaling $48.4 million, partially
offset by other-than-temporary impairments of $19.7 million
pre-tax.
Comparison with Competitors
Rival company Unitedhealth Group, Inc. (UNH)
reported its first quarter results on April 21, 2011 with income
from continuing operations of $1.22 per share, better than the
Zacks Consensus Estimate of 89 cents.
WellPoint’s peer -
Aetna
Inc. (AET) is scheduled to report its first quarter
of 2011 on April 28, followed by Humana Inc. (HUM)
on May 2 and CIGNA Corporation (CI) on May 5.
Outlook for Fiscal 2011
WellPoint anticipates a net income of at least $6.70 per share,
including net investment gains of 10 cents per share. This is an
increase from the previous estimate of $6.30 per share.
Further, this outlook includes no investment gains or losses
beyond those recorded during the first quarter of 2011.
In addition, WellPoint also anticipates year-end 2011 medical
enrollment to be approximately 33.9 million members.
Operating revenue is expected to be approximately $59.9
billion for
fiscal 2011, while operating cash flow is expected to be
approximately $2.7 billion.
For fiscal 2011, WellPoint also expects its benefit expense
ratio to be approximately 84.8%, with SG&A expense ratio to be
approximately 14.2%.
Our Recommendation
WellPoint has a strong cash flow generation, leading market
share positions, diversified product portfolio, proven track record
of execution, attractive valuation, and consistency that would
provide long-term value to its investors. Meanwhile, WellPoint has
been increasing its premiums and controlling costs.
Further, WellPoint is well positioned among its peer group and
has been strengthening its portfolio through its acquisition
strategy, the synergies of which are expected to lead to margin
expansion and top-line growth. Moreover, the sale of its in-house
pharmacy benefits business to Express Script has strengthened its
balance sheet and fueled buybacks.
Though we are pleased with the strong results of WellPoint along
with solid capital management, we remain wary of the impact of the
health insurance reforms and expect these reforms to likely
overshadow the stock.
Currently, WellPoint carries a Zacks #2 Rank, which translates
into a short-term Buy recommendation, indicating upward directional
pressure on the stock over the near term.
AETNA INC-NEW (AET): Free Stock Analysis Report
CIGNA CORP (CI): Free Stock Analysis Report
EXPRESS SCRIPTS (ESRX): Free Stock Analysis Report
HUMANA INC NEW (HUM): Free Stock Analysis Report
UNITEDHEALTH GP (UNH): Free Stock Analysis Report
WELLPOINT INC (WLP): Free Stock Analysis Report
Zacks Investment Research
Aetna (NYSE:AET)
Historical Stock Chart
From May 2024 to Jun 2024
Aetna (NYSE:AET)
Historical Stock Chart
From Jun 2023 to Jun 2024